San Antonio, Texas, USA, July 23, 2012 (GLOBE NEWSWIRE) -- Keraplast Technologies announced today the release of Keras, a comprehensive skin care system available exclusively from dermatologists, plastic surgeons, spas and clinics under physician direction. Incorporating the latest advancement in wound treatment, the Keras system uses the well proven Replicine™ Functional Keratin® wound care technology to provide improved healing after skin treatments, such as chemical peels, microdermabrasions or laser treatments, reducing down time and improving the cosmetic outcome, as well as a full range of at home care products to rebuild skin structure through an ongoing regimen. Dr Robert Allen Smith, MD, Plastic Surgeon and Clinical Director of Keraplast Technologies said "To achieve advanced wound healing requires genuine functionality from proven technologies that actually help the skin improve. Replicine™ Functional Keratin® wound care products have been providing significant benefits to a wide range of patients with moderate and severely damaged skin. The same healing processes occur in the intentional wounds created during skin treatments. The use of a proven wound healing technology to improve cosmetic outcome is a fantastic innovation."
Recent peer review scientific publications describe University of Miami research identifying that Replicine™ Functional Keratin® helps speed healing and helps skin cells make more collagen 4 and collagen 7. These particular proteins are crucial for rebuilding healthy skin structure following injury, and are also the specific collagens degraded at the base of each wrinkle during the ageing process. Professor Robert Kirsner, MD, Vice Chairman & Stiefel Laboratories Chair Department of Dermatology & Cutaneous Surgery and Chief of Dermatology University of Miami School of Medicine said "The understanding of the role that keratin proteins play in skin biology and wound care is emerging science and expanding at a rapid rate. The use of keratin is real innovation and can be seen as a new paradigm in wound healing".
The Keras system extends the use of advanced wound care technology to a complete skin care regimen, incorporating all the essential products needed for daily skin care, including Intensive Serum, Microdermabrasion Cream, SPF Day Shield, Night Renewal, Gel Cleanser and Eye Gel. "Keraplast focuses on providing proven scientific and medical advancements in a useful way that makes a positive difference to the everyday lives of our customers. We work across many fields, and so the extension of an advanced wound care technology to dermatology and skin care is natural for us, whereas other companies do not have access to the same medical advancements" said Michael Espensen, Chief Executive Officer of Keraplast Technologies.
More information on the Keras skin care system is available from www.kerasusa.com, or by contacting Victoria Gabrik, 678-910-3852
Keraplast Technologies LLC, a privately held company founded in 1996, is the world's leading developer and manufacturer of keratin products. Headquartered in San Antonio, Texas, Keraplast manufactures Replicine™ Functional Keratin® wound care products with FDA and CE mark clearance for sale around the world, as well as a wide range of skin care, hair care and nutritional solutions using proprietary keratin technology.